• Explore /
  • Poster
  • / Results of a phase I study of GS-5745 in combination with mFOLFOX in patients with advanced unresectable gastric / GE junction tumors.

Results of a phase I study of GS-5745 in combination with mFOLFOX in patients with advanced unresectable gastric / GE junction tumors.

Abstract Poster

Authors

Manish Shah

Manish A. Shah

Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY

Manish A. Shah , Alexander Starodub , Zev A. Wainberg , Meihua Wu , Victoria Smith , Julia D. Maltzman , Johanna C. Bendell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT01803282

Citation

J Clin Oncol 34, 2016 (suppl; abstr 4033)

DOI

10.1200/JCO.2016.34.15_suppl.4033

Abstract #

4033

Poster Bd #

25

Abstract Disclosures

Similar Posters

First Author: Lin Shen

First Author: David R. Spigel

First Author: Sun Young Rha

First Author: Lin Shen